Crescent Biopharma(CBIO.US)

Event Tracking

Feb27

Crescent Biopharma released FY2025 Annual Earnings on February 26 (EST), actual revenue USD 10.84 M (forecast USD 7.5 M), actual EPS USD -12.8149 (forecast USD -11.13)

04:00

Crescent Biopharma released FY2025 Q4 earnings on February 26, 2026 (EST), actual revenue USD 10.84 M (forecast USD 7.5 M), actual EPS USD -3.3529 (forecast USD -2.5162)

04:00

Jan4

Sichuan Kalen Biomedical's SKB105 Receives NMPA Clinical Trial Approval and Establishes Strategic Partnership

11:56

Dec4

CoLon Biotech and Crescent Biopharma Enter into Collaboration for Oncology Drug Development

11:48

Crescent Biopharma and Kelun-Biotech Partner to Develop Novel Cancer Treatments

11:30

Nov10

H.C. Wainwright Reiterates Buy Rating on Crescent Biopharma

11:56